Works matching DE "RIFAXIMIN"

Results: 162

Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin.

Published in:

Digestive Diseases, 2022, v. 40, n. 3, p. 313, doi. 10.1159/000518067

By:

Kubota, Kousuke;
Uojima, Haruki;
Shao, Xue;
Iwasaki, Shuichiro;
Hidaka, Hisashi;
Wada, Naohisa;
Nakazawa, Takahide;
Shibuya, Akitaka;
Kako, Makoto;
Koizumi, Wasaburo

Publication type:

Article

The Liver Meeting 2024: Bausch Health Presents Phase 3 Study Design for Investigational Rifaximin Formulation to Delay OHE.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Monotherapy with Rifaximin vs Lactulose More Effective for Reducing Recurrence of Overt Hepatic Encephalopathy: New Post Hoc Analysis.

Published in:

Patient Care (Online), 2024, p. 3

By:

Halsey, Grace

Publication type:

Article

Ameliorative Effect of L-carnitine VS L-carnitine with Rifaximin on Skeletal Muscle Changes in Experimentally Induced Liver Cirrhosis in Adult Male Albino Rats (Biochemical and Histological Study).

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 1, p. 279, doi. 10.21608/ZUMJ.2023.242977.2964

By:

Abd Elbaki, Bassant T.;
Elsammak, Ghada A.;
Soliman, Eman Khaled;
Elsayed, Basma Said;
Mostafa, Samar Abdelaziz

Publication type:

Article

Gastrointestinal Involvement in Systemic Sclerosis - Review of 250 Patients' Clinical, Radiological and Serological Profile - A Retrospective Study.

Published in:

2024

By:

Jacob, Manna;
Mathew, Ashish;
Nithin, Koshy;
Goel, Ruchika;
Mathew, John

Publication type:

Abstract

Rifaximin Treatment of Collagenous Colitis: A Randomised, Double-Blind, Placebo-Controlled Trial.

Published in:

Inflammatory Intestinal Diseases, 2024, v. 9, n. 1, p. 22, doi. 10.1159/000536124

By:

Becker, Sabine;
Grode, Louise B.;
Bonderup, Ole K.

Publication type:

Article

Efficacy of Rifaximin and Probiotics in the Treatment of Small Intestinal Bacterial Overgrowth When Used Concomitantly or Sequentially.

Published in:

Jordan Medical Journal, 2024, v. 58, n. 4, p. 389, doi. 10.35516/jmj.v58i4.1162

By:

Abu-Hammour, Adnan;
Abu-Hammour, Mohamad-Noor;
Al-Sheyyab, Ahmad;
Dajani, Asad

Publication type:

Article

Influence of Covid-19 disease on hemostasis dynamics during extracorporeal membrane oxygenation (ECMO)<sup>1</sup>.

Published in:

Clinical Hemorheology & Microcirculation, 2024, v. 87, n. 1, p. 1, doi. 10.3233/CH-229105

By:

Rother, D.;
Gehron, J.;
Brenck, F.;
Hudel, H.;
Böning, A.;
Wenzel, F.

Publication type:

Article

Post Marketing Observational Study of Fixed Dose Combination of Rifaximin and Metronidazole in The Management of Acute Diarrhea.

Published in:

Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy, 2023, v. 24, n. 2, p. 122, doi. 10.24871/2422023122-126

By:

Faruqui, Arif A.;
Shaikh, Shaguphta T.;
Ali, Faaria

Publication type:

Article

Fluoroquinolones for the Prophylaxis of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis: Are They Losing Ground?

Published in:

Life (2075-1729), 2025, v. 15, n. 4, p. 586, doi. 10.3390/life15040586

By:

Juncu, Simona;
Minea, Horia;
Lungu, Andreea;
Jucan, Alina;
Avram, Raluca;
Buzuleac, Ana-Maria;
Cojocariu, Camelia;
Diaconu, Laura Sorina;
Stanciu, Carol;
Trifan, Anca;
Sîngeap, Ana-Maria

Publication type:

Article

Comparison of Rifaximin Monotherapy and Rifaximin Combined with Probiotics in Patients with Irritable Bowel Syndrome: A Randomized Controlled Trial.

Published in:

Nutrients, 2025, v. 17, n. 5, p. 763, doi. 10.3390/nu17050763

By:

Oh, Chang Kyo;
Chung, Hwe Hoon;
Kim, Yu Jin;
Kim, Jin Bae

Publication type:

Article

Rifaximin Ameliorates Loperamide-Induced Constipation in Rats through the Regulation of Gut Microbiota and Serum Metabolites.

Published in:

Nutrients, 2023, v. 15, n. 21, p. 4502, doi. 10.3390/nu15214502

By:

Luo, Mei;
Xie, Peiwei;
Deng, Xuehong;
Fan, Jiahui;
Xiong, Lishou

Publication type:

Article

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.

Published in:

PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203200

By:

Kimer, Nina;
Gudmann, Natasja Stæhr;
Pedersen, Julie Steen;
Møller, Søren;
Nielsen, Mette Juul;
Leeming, Diana Julie;
Karsdal, Morten Asser;
Møller, Holger Jon;
Bendtsen, Flemming;
Grønbæk, Henning

Publication type:

Article

Drug Utilization of Rifaximin-α in Patients with Hepatic Encephalopathy: Evidence from Real Clinical Practice in Italy.

Published in:

Medicina (1010660X), 2025, v. 61, n. 2, p. 221, doi. 10.3390/medicina61020221

By:

Perrone, Valentina;
Usala, Marcello;
Veronesi, Chiara;
Cappuccilli, Maria;
Degli Esposti, Luca

Publication type:

Article

Adherence to rifaximin initiation and prescribing within King's College Hospital and transfer of prescribing to primary care.

Published in:

2023

By:

Monk, G;
Shah, S

Publication type:

Abstract

利福昔明联合枯草杆菌二联活菌治疗小肠细菌过度生长的研究.

Published in:

Journal of Practical Medicine / Shiyong Yixue Zazhi, 2023, v. 39, n. 14, p. 1815, doi. 10.3969/j.issn.1006-5725.2023.14.015

By:

于兰;
闫志辉;
罗哲;
郑岩;
崔立红

Publication type:

Article

Evaluation of Combining Ability and Heterosis for Earliness and Growth Traits of some Sunflower Genotypes under Water Stress Conditions.

Published in:

Journal of Plant Production, 2022, v. 13, n. 8, p. 565, doi. 10.21608/jpp.2022.151438.1145

By:

Abdel-Moneam;
Abdelsatar, M. A.;
Hafez, Soad H.;
Gomaa, Alaa A.

Publication type:

Article

Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis.

Published in:

Antibiotics (2079-6382), 2025, v. 14, n. 3, p. 287, doi. 10.3390/antibiotics14030287

By:

Bai, Zhaohui;
Li, Congcong;
Lai, Yongjie;
Hu, Xiaojuan;
Shi, Luwen;
Guan, Xiaodong;
Xu, Yang

Publication type:

Article

Diverticular Disease and Rifaximin: An Evidence-Based Review.

Published in:

Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 443, doi. 10.3390/antibiotics12030443

By:

Piccin, Anna;
Gulotta, Marco;
di Bella, Stefano;
Martingano, Paola;
Crocè, Lory Saveria;
Giuffrè, Mauro

Publication type:

Article

Synthetic Imidazopyridine-Based Derivatives as Potential Inhibitors against Multi-Drug Resistant Bacterial Infections: A Review.

Published in:

Antibiotics (2079-6382), 2022, v. 11, n. 12, p. 1680, doi. 10.3390/antibiotics11121680

By:

Sanapalli, Bharat Kumar Reddy;
Ashames, Akram;
Sigalapalli, Dilep Kumar;
Shaik, Afzal B.;
Bhandare, Richie R.;
Yele, Vidyasrilekha

Publication type:

Article

Mean Blood Ammonia Level After Treatment With Rifaximin Versus Neomycin In Chronic Liver Disease Patients Presenting With Hepatic Encephalopathy.

Published in:

Annals of King Edward Medical University, 2019, v. 25, n. 1, p. 1

By:

Mumtaz, Sami Ullah;
Iqtadar, Somia;
Niaz, Zafar;
Komal, Tayyeba;
Abaidullah, Sajid

Publication type:

Article

An animal model of limitation of gut colonization by carbapenemase-producing Klebsiella pneumoniae using rifaximin.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07827-8

By:

Xenofontos, Eleni;
Renieris, Georgios;
Kalogridi, Maria;
Droggiti, Dionyssia-Eirini;
Synodinou, Kalliopi;
Damoraki, Georgia;
Koufargyris, Panagiotis;
Sabracos, Labros;
Giamarellos-Bourboulis, Evangelos J.

Publication type:

Article

Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06416-z

By:

Ballester, María-Pilar;
Gallego, Juan-José;
Fiorillo, Alessandra;
Casanova-Ferrer, Franc;
Giménez-Garzó, Carla;
Escudero-García, Desamparados;
Tosca, Joan;
Ríos, María-Pilar;
Montón, Cristina;
Durbán, Lucía;
Ballester, José;
Benlloch, Salvador;
Urios, Amparo;
San-Miguel, Teresa;
Kosenko, Elena;
Serra, Miguel-Ángel;
Felipo, Vicente;
Montoliu, Carmina

Publication type:

Article

Perioperative rifaximin is not associated with enhanced functional and volumetric recovery after major liver resection.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97442-w

By:

Bednarsch, Jan;
Czigany, Zoltan;
Loosen, Sven H.;
Heij, Lara;
Ruckgaber, Lorenz;
Maes, Henning;
Krause, Jan-Pit;
Reen, Matthias;
Toteva, Beata;
Vosdellen, Theresa;
Bruners, Philipp;
Lang, Sven Arke;
Ulmer, Tom Florian;
Roderburg, Christoph;
Luedde, Tom;
Neumann, Ulf Peter

Publication type:

Article

Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97018-8

By:

Flatt, Emmanuelle;
McLin, Valérie A.;
Braissant, Olivier;
Pierzchala, Katarzyna;
Mastromarino, Paola;
Mitrea, Stefanita-Octavian;
Sessa, Dario;
Gruetter, Rolf;
Cudalbu, Cristina

Publication type:

Article

Norfloxacin versus rifaximin for spontaneous bacterial peritonitis prophylaxis: A randomized controlled trial.

Published in:

Journal of Krishna Institute of Medical Sciences (JKIMSU), 2024, v. 13, n. 1, p. 112

By:

Pala, Sanbanki;
Doke, Purwa;
Maindad, Dadasaheb

Publication type:

Article

Preparation of S-Scheme g-C 3 N 4 /ZnO Heterojunction Composite for Highly Efficient Photocatalytic Destruction of Refractory Organic Pollutant.

Published in:

Catalysts (2073-4344), 2023, v. 13, n. 3, p. 485, doi. 10.3390/catal13030485

By:

Sert, Buse;
Bilici, Zeynep;
Ocakoglu, Kasim;
Dizge, Nadir;
Rad, Tannaz Sadeghi;
Khataee, Alireza

Publication type:

Article

Bismuth subsalicylate, probiotics, rifaximin and vaccines for the prevention of travelers' diarrhea: a systematic review and network meta-analysis.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1361501

By:

Hao Fan;
I-Chun Liu;
Lei Gao;
Lanka Wu

Publication type:

Article

Review article: post‐TIPSS hepatic encephalopathy—current knowledge and future perspectives.

Published in:

Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 10, p. 1265, doi. 10.1111/apt.16825

By:

Gairing, Simon Johannes;
Müller, Lukas;
Kloeckner, Roman;
Galle, Peter R.;
Labenz, Christian

Publication type:

Article

Editorial: infections and hepatic encephalopathy–does the chicken or the egg come FIRST? A novel perspective at the horizon.

Published in:

2022

By:

Riggio, Oliviero;
Ridola, Lorenzo

Publication type:

Editorial

Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 435, doi. 10.1111/apt.15326

By:

Salehi, Shayon;
Tranah, Thomas H.;
Lim, Samuel;
Heaton, Nigel;
Heneghan, Michael;
Aluvihare, Varuna;
Patel, Vishal C.;
Shawcross, Debbie L.

Publication type:

Article

Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1029, doi. 10.1111/apt.14361

By:

Goel, A.;
Rahim, U.;
Nguyen, L. H.;
Stave, C.;
Nguyen, M. H.

Publication type:

Article

Irritable bowel syndrome in adolescents.

Published in:

Journal of Alternative Medicine Research, 2023, v. 15, n. 4, p. 407

By:

Schmalz, Michael;
Gomes, Theotonius J.

Publication type:

Article

STUDY TO DETERMINE THE EFFICACY OF RIFAXIMIN AS A PROPHYLACTIC ANTIBIOTIC FOR ILEOSTOMY CLOSURE AND TO COMPARE WOUND INFECTION RATES WITH THOSE OF OTHER CONVENTIONAL ANTIBIOTICS.

Published in:

Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2023, v. 14, n. 6, p. 717

By:

Vardhan, Kirti;
Kumar, Yogesh;
Seth, Vikas;
Singh, Amresh Pratap;
Mathur, Sujeet Kumar;
Jaiswal, Rahul;
Mishra, Apoorv;
Kumar, Sunil;
Maurya, Ranjit;
Shubhanwesi

Publication type:

Article

THE ROLE OF ANTIBIOTICS, RIFAXIMIN VERSUS CIPROFLOXACIN IN INDUCTION OF REMISSION IN ULCERATIVE COLITIS.

Published in:

Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2021, v. 12, n. 5, p. 211

By:

Alam, Intikhab;
Khan, Muhammad Rafique;
Ur Rehman, Zahoor;
Ahmed, Younas;
Nadeem, Ramsha;
Sibtain, Zaeem;
Rafique, Zohra

Publication type:

Article

Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat.

Published in:

Journal of Neuroinflammation, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12974-021-02303-y

By:

Li, Haonan;
Xiang, Yujiao;
Zhu, Zemeng;
Wang, Wei;
Jiang, Zhijun;
Zhao, Mingyue;
Cheng, Shuyue;
Pan, Fang;
Liu, Dexiang;
Ho, Roger C. M.;
Ho, Cyrus S. H.

Publication type:

Article

Preparation of Porous Novel QuEChERS Adsorbent ZIF‐67/PAA/PES Composite Microspheres and Their Application for Rapid Adsorption of Triphenylmethane Dyes in Wastewater and Fish.

Published in:

Polymers for Advanced Technologies, 2025, v. 36, n. 1, p. 1, doi. 10.1002/pat.70031

By:

Wang, Xiaotian;
Aheyeli‐kai, Yeerken;
Ying, Huakun;
Lin, Jiangli;
Luo, Yulu;
Ma, Hongying;
Li, Zhongyang;
Su, Zhen

Publication type:

Article

An Effectiveness of Ayurveda Management in Crohn's Disease.

Published in:

Journal of Integrated Health Sciences, 2024, v. 12, n. 1, p. 80, doi. 10.4103/jihs.jihs_13_24

By:

Varsakiya, Jitendrakumar Nathabhai;
Agarwal, Bhawana;
Kathad, Divyarani;
Ravi, Arun Kumar;
Dwivedi, Shiv Prasad

Publication type:

Article

Efficiency of management of patients with irritable bowel syndrome with constipation and autoimmune thyroiditis with hypothyroidism using rifaximin.

Published in:

International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal, 2025, v. 21, n. 2, p. 190, doi. 10.22141/2224-0721.21.2.2025.1502

By:

Onofrijchuk, Yu. A.

Publication type:

Article

만성췌장염에서 췌장암의 감시.

Published in:

Korean Journal of Pancreas & Biliary Tract / Daehan Chwedamdo Haghoeji, 2022, v. 27, n. 3, p. 116, doi. 10.15279/kpba.2022.27.3.116

By:

장재혁

Publication type:

Article

Severe Ulcerative Colitis Complicated by Malakoplakia Resulting in Proctocolectomy.

Published in:

ACG Case Reports Journal, 2024, v. 11, n. 1, p. 1, doi. 10.14309/crj.0000000000001257

By:

Alphonsus, Lotus;
De Silva, Theshani A.;
Driman, David;
Jairath, Vipul

Publication type:

Article

Comparative UV Spectroscopic Method Analysis and Validation for Estimation of Rifaximin in Pharmaceutical Preparation.

Published in:

Journal of Drug Delivery & Therapeutics, 2023, v. 13, n. 9, p. 33, doi. 10.22270/jddt.v13i9.6193

By:

Joice, Aney;
Sange, Farheen Mohammed Zubair

Publication type:

Article

Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model.

Published in:

Biomedical Reports, 2025, v. 22, n. 1, p. N.PAG, doi. 10.3892/br.2024.1882

By:

Longo, Larisse;
Guerreiro, Gabriel Tayguara Silveira;
Behrens, Luiza;
Pereira, Matheus Henrique Mariano;
Pinzon, Carlos Eduardo;
Cerski, Carlos Thadeu Schmidt;
Uribe-Cruz, Carolina;
Álvares-da-Silva, Mário Reis

Publication type:

Article

Volatile cinnamaldehyde induces systemic salt tolerance in the roots of rice (Oryza sativa).

Published in:

Physiologia Plantarum, 2023, v. 175, n. 3, p. 1, doi. 10.1111/ppl.13938

By:

Huang, Chung‐Chih;
Lee, Yun‐Ting;
Ly, Thach‐Thao;
Wang, Chong‐Yue;
Chang, Yao‐Tsung;
Hou, Ping‐Fu;
Liu, Zin‐Huang;
Huang, Hao‐Jen

Publication type:

Article

Rifaximin in gut microbiota modification in acute pancreatitis: 15 years of retrospective clinical study.

Published in:

Advances in Clinical & Experimental Medicine, 2022, v. 31, n. 4, p. 399, doi. 10.17219/acem/144993

By:

Tatur, Jacek;
Lipiński, Michał;
Sznurkowska, Marta;
Józefik, Ewa;
Rydzewska, Grażyna

Publication type:

Article

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-54117-6

By:

Jørgensen, S. F.;
Macpherson, M. E.;
Bjørnetrø, T.;
Holm, K.;
Kummen, M.;
Rashidi, A.;
Michelsen, A. E.;
Lekva, T.;
Halvorsen, B.;
Trøseid, M.;
Mollnes, T. E.;
Berge, R. K.;
Yndestad, A.;
Ueland, T.;
Karlsen, T. H.;
Aukrust, P.;
Hov, J. R.;
Fevang, B.

Publication type:

Article

A comparative study to determine the short-term mortality and clinical improvement in hepatic encephalopathy using either rifaximin and or lactulose.

Published in:

Asian Journal of Medical Sciences, 2021, v. 12, n. 3, p. 46, doi. 10.3126/ajms.v12i3.32808

By:

Biswas, Uttam;
Pal, Shyamal Kanti;
Chaudhuri, Pallabi Ray;
Roychowdhury, Debanjan;
Dhar, Abhranil;
Roy, Anirudhdha

Publication type:

Article

Efficacy of a 1 day Rifaximin and Metronidazole Regimen and Mechanical Bowel Preparation for Preventing Surgical Site Infection in Minimally Invasive Colorectal Cancer Surgery: A Prospective Observational Study.

Published in:

American Surgeon, 2024, v. 90, n. 4, p. 550, doi. 10.1177/00031348231200667

By:

Yoon, Seung-Hwan;
Yang, In Jun;
Kim, Ji Yeon;
Lee, Kyung-Ha

Publication type:

Article

Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier.

Published in:

Therapeutics & Clinical Risk Management, 2023, v. 19, p. 839, doi. 10.2147/TCRM.S425292

By:

Torre, Aldo;
Córdova-Gallardo, Jacqueline;
Munari, Alberto C Frati

Publication type:

Article

Efficacy and safety of rifaximin in preventing hepatic encephalopathy: A systematic review and meta-analysis.

Published in:

PLoS ONE, 2025, v. 20, n. 5, p. 1, doi. 10.1371/journal.pone.0323359

By:

Hu, Yangyang;
Zhang, Xing;
Xiao, Ying;
Wu, Zhinian;
Wang, Yadong

Publication type:

Article